Alderline Group

Funding rounds backed by Alderline Group.

Export CSV
Funding disclosed in full
$357M
Median round
$178.5M
Rounds in calculation
2
2 rounds
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Third Arc Bio

Develops novel multifunctional antibodies for oncology and immunology & inflammation indications

$52MSeries A+BiotechUnited States
11 participantsAbbVie VenturesabrdnAlderline GroupAndreessen Horowitz (a16z)BVF Partners LPGalapagos NVGoldman Sachs Alternatives Life SciencesHillhouse InvestmentMarshall WaceOmega FundsT. Rowe Price Associates
Parabilis Medicines

Develops medicines targeting historically undruggable protein targets in cancer

$305MSeries FBiotechUnited States
23 participantsAlderline GroupARCH Venture PartnersCatalio Capital ManagementCormorant Asset ManagementFarallon Capital ManagementFidelity Management & Research CompanyForesite CapitalFrazier Life SciencesGeneral CatalystGV (Google Ventures)HBM HealthcareInvusJanus Henderson InvestorsMarshall WaceMilky Way InvestmentsNextech InvestRA Capital ManagementRock Springs CapitalSamsara BioCapitalSixty Degree CapitalSoleus CapitalT. Rowe Price AssociatesvenBio Partners